These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30247545)

  • 1. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
    Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
    Carcinogenesis; 2019 Mar; 40(1):52-60. PubMed ID: 30247545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.
    Wen Y; An Z; Qiao B; Zhang C; Zhang Z
    Urol Oncol; 2019 May; 37(5):297.e1-297.e7. PubMed ID: 30737160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma.
    Wang J; Kim J; Roh M; Franco OE; Hayward SW; Wills ML; Abdulkadir SA
    Oncogene; 2010 Apr; 29(17):2477-87. PubMed ID: 20140016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells.
    Wang J; Anderson PD; Luo W; Gius D; Roh M; Abdulkadir SA
    Oncogene; 2012 Apr; 31(14):1794-803. PubMed ID: 21860423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.
    Kirschner AN; Wang J; van der Meer R; Anderson PD; Franco-Coronel OE; Kushner MH; Everett JH; Hameed O; Keeton EK; Ahdesmaki M; Grosskurth SE; Huszar D; Abdulkadir SA
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells.
    Sagar V; Caldarola S; Aria V; Monteleone V; Fuoco C; Gargioli C; Cannata S; Loreni F
    Oncotarget; 2016 Apr; 7(17):23837-49. PubMed ID: 26993775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
    Rebello RJ; Kusnadi E; Cameron DP; Pearson HB; Lesmana A; Devlin JR; Drygin D; Clark AK; Porter L; Pedersen J; Sandhu S; Risbridger GP; Pearson RB; Hannan RD; Furic L
    Clin Cancer Res; 2016 Nov; 22(22):5539-5552. PubMed ID: 27486174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression.
    Iadevaia V; Caldarola S; Biondini L; Gismondi A; Karlsson S; Dianzani I; Loreni F
    Oncogene; 2010 Oct; 29(40):5490-9. PubMed ID: 20639905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.
    Brasó-Maristany F; Filosto S; Catchpole S; Marlow R; Quist J; Francesch-Domenech E; Plumb DA; Zakka L; Gazinska P; Liccardi G; Meier P; Gris-Oliver A; Cheang MC; Perdrix-Rosell A; Shafat M; Noël E; Patel N; McEachern K; Scaltriti M; Castel P; Noor F; Buus R; Mathew S; Watkins J; Serra V; Marra P; Grigoriadis A; Tutt AN
    Nat Med; 2016 Nov; 22(11):1303-1313. PubMed ID: 27775704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
    Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H
    Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
    Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
    Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pim1 regulates androgen-dependent survival signaling in prostate cancer cells.
    van der Poel HG; Zevenhoven J; Bergman AM
    Urol Int; 2010; 84(2):212-20. PubMed ID: 20215828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction.
    Ye C; Zhang C; Huang H; Yang B; Xiao G; Kong D; Tian Q; Song Q; Song Y; Tan H; Wang Y; Zhou T; Zi X; Sun Y
    Cell Physiol Biochem; 2018; 48(3):1230-1244. PubMed ID: 30045021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of quinones as novel PIM1 kinase inhibitors.
    Schroeder RL; Goyal N; Bratton M; Townley I; Pham NA; Tram P; Stone T; Geathers J; Nguyen K; Sridhar J
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3187-3191. PubMed ID: 27173800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
    Holder SL; Abdulkadir SA
    Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
    Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
    Carcinogenesis; 2019 Mar; 40(1):202. PubMed ID: 30859224
    [No Abstract]   [Full Text] [Related]  

  • 20. RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis.
    Zhang W; Tong D; Liu F; Li D; Li J; Cheng X; Wang Z
    Oncotarget; 2016 Feb; 7(5):5800-14. PubMed ID: 26735579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.